From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

Decision Making in Mpox

First published:

2023

Last published:

2023

Overview

This 2-page quick reference tool provides guidance about mpox and can be used when making decisions on who to test, mpox management, and vaccination protocols.

This resource was published more than two years ago. Some information may be outdated or may not reflect current clinical evidence and guidelines. Please contact us with any queries.